{"id":34538,"date":"2026-04-17T10:32:45","date_gmt":"2026-04-17T05:02:45","guid":{"rendered":"https:\/\/signalz.pro\/?post_type=media-review&#038;p=34538"},"modified":"2026-04-28T15:20:54","modified_gmt":"2026-04-28T09:50:54","slug":"34538","status":"publish","type":"media-review","link":"https:\/\/signalz.pro\/media-review\/34538\/","content":{"rendered":"<p><strong>Zensar Technologies (ZENSARTECH)<\/strong> in 2026 centers on its aggressive pivot toward an &#8220;AI-first&#8221; strategy, strong fiscal management, and a deliberate shift in its vertical exposure.<\/p>\n<p>As of April 2026, here are the core pillars of the company&#8217;s growth rationale:<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li><strong> The &#8220;AI-Native&#8221; Pivot<\/strong><\/li>\n<\/ol>\n<p>Zensar has aggressively integrated Artificial Intelligence into its core operations, branding itself as an AI-native firm.<\/p>\n<ul>\n<li><strong>Order Book Momentum:<\/strong> Approximately <strong>20% to 28% of the new order book<\/strong> is now categorized as &#8220;AI-influenced,&#8221; showing that the company is successfully winning deals tied to GenAI and data engineering.<\/li>\n<li><strong>Workforce Readiness:<\/strong> Nearly <strong>60% of its workforce<\/strong> is AI-certified through its &#8220;Ignite AI Academy,&#8221; which has trained over 7,300 unique employees.<\/li>\n<li><strong>ZenseAI Platform:<\/strong> The company is leveraging its proprietary AI-led platform to secure high-value automation and enterprise modernization deals.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ol start=\"2\">\n<li><strong> Strategic Vertical Realignment<\/strong><\/li>\n<\/ol>\n<p>Zensar is actively rebalancing its portfolio to mitigate risks in volatile sectors:<\/p>\n<ul>\n<li><strong>Moving away from TMT:<\/strong> The company is reducing exposure to the <strong>Telecommunications, Media, and Technology (TMT)<\/strong> vertical, where clients have been cutting operating expenses to fund heavy capital expenditures (like GPUs).<\/li>\n<li><strong>Focus on BFSI &amp; Healthcare:<\/strong> It is doubling down on <strong>Banking, Financial Services, and Insurance (BFSI)<\/strong> and <strong>Healthcare<\/strong>, both of which have shown more resilient growth and increased digital spending.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ol start=\"3\">\n<li><strong> Financial Discipline &amp; Margin Expansion<\/strong><\/li>\n<\/ol>\n<p>Despite a challenging global macro environment, Zensar has maintained a strong focus on profitability:<\/p>\n<ul>\n<li><strong>EBITDA Margins:<\/strong> Management has consistently targeted and achieved margins in the <strong>mid-teens (15%\u201317.4%)<\/strong>. This has been driven by a &#8220;shift to offshore&#8221; strategy and higher employee utilization (around 84.8%).<\/li>\n<li><strong>Robust Cash Reserves:<\/strong> With a cash balance exceeding <strong>$320 million<\/strong>, the company is well-positioned for &#8220;revenue-enhancing&#8221; M&amp;A opportunities and consistent dividend payouts (the most recent being an interim dividend of \u20b92.4\/share).<\/li>\n<li><strong>Fiscal Tailwinds:<\/strong> The <strong>2026 Union Budget<\/strong> in India raised the safe harbor threshold for IT services to \u20b92,000 crore, providing Zensar with greater tax predictability and simplified compliance for its global operations.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ol start=\"4\">\n<li><strong> Valuation Context<\/strong><\/li>\n<\/ol>\n<p>Zensar is often viewed as an &#8220;attractive price&#8221; play compared to the broader IT sector:<\/p>\n<ul>\n<li><strong>P\/E Ratio:<\/strong> It currently trades at a P\/E of approximately <strong>17\u201318x<\/strong>, which is significantly lower than the sector average of ~36x.<\/li>\n<\/ul>\n<p><strong>Latest Financials<\/strong><\/p>\n<ol>\n<li><strong> Top-Line Performance (Revenue)<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Quarterly Revenue:<\/strong> Stood at <strong>$160.5 million<\/strong>, a modest <strong>2% YoY growth<\/strong> in reported currency (1.3% in Constant Currency).<\/li>\n<\/ul>\n<ul>\n<li><strong>Sequential Dip:<\/strong> Revenue saw a <strong>1.4% QoQ decline<\/strong>, primarily attributed to seasonal furloughs and a &#8220;soft&#8221; macro environment.<\/li>\n<li><strong>Vertical Performance:<\/strong> * <strong>BFSI:<\/strong> Strong growth at <strong>12.2% YoY<\/strong>.\n<ul>\n<li><strong>Healthcare:<\/strong> Steady growth at <strong>5.2% YoY<\/strong>.<\/li>\n<li><strong>TMT:<\/strong> Significant drag, declining <strong>11.6% YoY<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ol start=\"2\">\n<li><strong> Profitability &amp; Margins (The High Point)<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Net Profit:<\/strong> Jumped to <strong>\u20b9199.8 crore<\/strong>, representing a robust <strong>25% YoY increase<\/strong>.<\/li>\n<li><strong>EBITDA Margin:<\/strong> Improved significantly to <strong>17.4%<\/strong> (up 200 bps QoQ), beating management\u2019s typical mid-teens guidance.<\/li>\n<li><strong>PAT Margin:<\/strong> Recorded at <strong>13.9%<\/strong>, up from 12.1% in the same quarter last year.<\/li>\n<li><strong>Efficiency Drivers:<\/strong> Higher offshore mix (<strong>3.1% volume growth offshore<\/strong>) and tight operational discipline were the primary drivers for margin expansion.<\/li>\n<\/ul>\n<ol start=\"3\">\n<li><strong> Order Book &amp; Liquidity<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Order Book:<\/strong> Reached <strong>$180.2 million<\/strong>, showing a healthy <strong>13.6% QoQ growth<\/strong>.<\/li>\n<li><strong>Book-to-Bill Ratio:<\/strong> Stood at <strong>1.12<\/strong>, indicating a steady pipeline for the upcoming quarters.<\/li>\n<li><strong>Cash Position:<\/strong> Highest ever cash and cash equivalents at <strong>$322.4 million<\/strong> (up nearly $30M sequentially).<\/li>\n<li><strong>DSO (Days Sales Outstanding):<\/strong> Improved to <strong>71 days<\/strong>, reflecting efficient collection cycles.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ol start=\"4\">\n<li><strong> Workforce &amp; Operational Metrics<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Attrition:<\/strong> Remained stable and healthy at <strong>9.5%<\/strong>, staying below the 10% mark for four consecutive quarters.<\/li>\n<li><strong>Utilization:<\/strong> Dipped slightly to <strong>83.5%<\/strong> due to seasonality, but remains within the target range.<\/li>\n<li><strong>Dividend:<\/strong> The board declared an interim dividend of <strong>\u20b92.40 per share<\/strong> during this fiscal cycle.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/signalz.pro\/wp-content\/uploads\/2026\/04\/ZENSARTECH-RR-2.pdf\">ZENSARTECH RR-2<\/a><\/p>\n","protected":false},"comment_status":"closed","ping_status":"closed","template":"","media-category":[9],"media-subscription":[],"call-tags":[],"class_list":["post-34538","media-review","type-media-review","status-publish","hentry","media-category-stock-exchange"],"acf":[],"_links":{"self":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/34538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review"}],"about":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/types\/media-review"}],"replies":[{"embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/comments?post=34538"}],"version-history":[{"count":1,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/34538\/revisions"}],"predecessor-version":[{"id":34540,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/34538\/revisions\/34540"}],"wp:attachment":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media?parent=34538"}],"wp:term":[{"taxonomy":"media-category","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-category?post=34538"},{"taxonomy":"media-subscription","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-subscription?post=34538"},{"taxonomy":"call-tags","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/call-tags?post=34538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}